The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation
Abstract One of the hallmarks of the most common neurodegenerative disease, Alzheimer’s disease (AD), is the extracellular deposition and aggregation of Amyloid Beta (Aβ)-peptides in the brain. Previous studies have shown that select metal ions, most specifically copper (Cu) and zinc (Zn) ions, have...
Guardado en:
Autores principales: | Stéphane L. Benoit, Robert J. Maier |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0ec3b635d684dfc8f53839f454dbc95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nickel chelation therapy as an approach to combat multi-drug resistant enteric pathogens
por: Stéphane L. Benoit, et al.
Publicado: (2019) -
Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
por: Sun-Ho Han, et al.
Publicado: (2010) -
Synthesis and structure of condensation product of dimethylglyoxime on gold matri
por: Bouroş, Pavlina, et al.
Publicado: (2008) -
Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology.
por: Gözde Eskici, et al.
Publicado: (2013) -
A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles
por: Xing Y, et al.
Publicado: (2017)